Skip to main content

Angeliq FDA Approval History

FDA Approved: Yes (First approved September 28, 2005)
Brand name: Angeliq
Generic name: drospirenone and estradiol
Dosage form: Tablets
Company: Berlex, Inc.
Treatment for: Postmenopausal Symptoms

Angeliq is a hormone replacement therapy containing estradiol and the progestin drospirenone, a hormone that counters the excess water and sodium buildup that is a side effect of estradiol. Angeliq is used to treat moderate to severe menopausal symptoms, such as hot flashes and vaginal dryness.

Development timeline for Angeliq

Feb 29, 2012Approval U.S. FDA Approves Lower Dose Formulation of Angeliq (drospirenone and estradiol) Tablets
Sep 28, 2005Approval Angeliq Berlex, Inc. - Treatment for Menopausal Symptoms
Sep 15, 2004FDA Issues Approvable Letter to Berlex Laboratories for Angeliq

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.